$6.97 Billion Photodynamic Therapy Market Outlook, 2024-2032, Featuring Detailed Analysis of Gladerma, Sun Pharmaceutical Industries, Biofrontera, Lumibird, Bausch Health Companies, and More
06 juin 2024 04h22 HE
|
Research and Markets
Dublin, June 06, 2024 (GLOBE NEWSWIRE) -- The "Photodynamic Therapy Market Report by Product Types, Application, End-user, Countries and Company Analysis 2024-2032" report has been added to ...
Vidac Pharma receives US patent office Notice of Allowance for crucial compounds in its cancer drug candidates
03 juin 2024 01h30 HE
|
Vidac Pharma Holding PLC
London (UK), June 3, 2024 (07:30 CET) – Vidac Pharma Holdings Plc. (Hamburg and Stuttgart: T9G; ISIN:GB00BM9XQ619; WKN: A3DTUQ), a clinical-stage oncology biopharmaceutical company pioneering a novel...
Derm-Biome Pharmaceuticals’ topical therapy shows positive results in preclinical skin cancer trial: drug prevents the development of precancerous skin conditions and treats existing skin cancers with no observable side effects.
17 avr. 2024 10h15 HE
|
Derm-Biome Pharmaceuticals, Inc
VANCOUVER, British Columbia, April 17, 2024 (GLOBE NEWSWIRE) -- The rates of precancerous skin conditions and skin cancers are soaring in many parts of the world. Actinic keratosis (AK) is the most...
Vidac Pharma receives Japanese Patent Office Notice of Allowance for VDA-1275 cancer drug candidate
27 mars 2024 02h30 HE
|
Vidac Pharma Holding PLC
Vidac Pharma receives Japanese Patent Office Notice of Allowance for VDA-1275 cancer drug candidate London (UK), March 27, 2024 (07:30 CET) – Vidac Pharma Holdings Plc. (Hamburg and Stuttgart: T9G;...
Global Photodynamic Therapy Devices Market Report 2024: Analysis of Products, Applications, End-users and Regional Dynamics to 2034 Featuring Coherent Corp, Biolitec, & Lumibird Medical Among Other Key Players
11 mars 2024 14h11 HE
|
Research and Markets
Dublin, March 11, 2024 (GLOBE NEWSWIRE) -- The "Global Photodynamic Therapy Devices Market Analysis & Forecast to 2024-2034: Market By Product; By Application; By End-user; and By Region" report...
Vidac Pharma va mener une étude de phase 2b du VDA-1102, son candidat médicament pour le traitement de la kératose actinique en collaboration avec CentroDerm
19 déc. 2023 01h00 HE
|
Vidac Pharma Holding PLC
Londres (Royaume-Uni), 19 décembre 2023 – Vidac Pharma Holding Plc (Hambourg et Stuttgart : T9G ; ISIN : GB00BM9XQ619 ; WKN : A3DTUQ), société biopharmaceutique d'oncologie de stade clinique, a...
Vidac Pharma to conduct Phase 2b study for actinic keratosis therapeutic candidate VDA-1102 with CentroDerm
19 déc. 2023 01h00 HE
|
Vidac Pharma Holding PLC
London (UK), December 19, 2023 – Vidac Pharma Holdings Plc. (Hamburg and Stuttgart: T9G; ISIN:GB00BM9XQ619; WKN: A3DTUQ), a clinical-stage oncology biopharmaceutical company, has completed...
Derm-Biome Pharmaceuticals Announces Collaboration with Massachusetts General Hospital in Skin Cancer Study
28 nov. 2023 10h00 HE
|
Derm-Biome Pharmaceuticals, Inc
VANCOUVER, British Columbia, Nov. 28, 2023 (GLOBE NEWSWIRE) -- Derm-Biome Pharmaceuticals Inc, a Vancouver based biopharmaceutical company with a focus on skin disease, is excited to announce that...
Global Photodynamic Therapy Market Analysis & Forecast 2024-2034: Innovations in Photodynamic Therapy Devices Propel Growth, with Cancer Treatment and Skin Conditions at the Forefront
02 nov. 2023 10h03 HE
|
Research and Markets
Dublin, Nov. 02, 2023 (GLOBE NEWSWIRE) -- The "Global Photodynamic Therapy Market Analysis & Forecast 2024-2034: Market By Product; By Applications; By End-user; and By Region" report has been...
Photodynamic Therapy Market to Grow at a CAGR of 13.5% from 2022 to 2031, reaching US$ 15.5 Billion: As per TMR Study
17 juil. 2023 15h30 HE
|
Transparency Market Research
Wilmington, Delaware, United States, July 18, 2023 (GLOBE NEWSWIRE) -- The global photodynamic therapy market stood at US$ 4.2 billion in 2021, and the global market is projected to reach US$ 15.5...